27655678|t|RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells
27655678|a|Myeloid-derived-suppressor cells (MDSCs) are key mediators of immune suppression in the ovarian tumor microenvironment. Modulation of MDSC function to relieve immunosuppression may enhance the immunologic clearance of tumors. The bis-benzylidine piperidone RA190 binds to the ubiquitin receptor RPN13/ADRM1 on the 19S regulatory particle of the proteasome and directly kills ovarian cancer cells by triggering proteotoxic stress. Here we examine the effect of RA190 treatment on the immunosuppression induced by MDSCs in the tumor microenvironment, specifically on the immunosuppression induced by MDSCs. We show that RA190 reduces the expression of Stat3 and the levels of key immunosuppressive enzymes and cytokines arginase, iNOS, and IL-10 in MDSCs, while boosting expression of the immunostimulatory cytokine IL-12. Furthermore, we show that the RA190 -treated MDSCs lost their capacity to suppress CD8+ T cell function. Finally, we show that RA190 treatment of mice bearing syngeneic ovarian tumor elicits potent CD8+ T cell antitumor immune responses and improves tumor control and survival. These data suggest the potential of RA190 for ovarian cancer treatment by both direct killing of tumor cells via proteasome inhibition and relief of MDSC -mediated suppression of CD8 T cell -dependent antitumor immunity elicited by the apoptotic tumor cells.
27655678	0	11	RPN13/ADRM1	T116,T123	C1439083
27655678	12	21	inhibitor	T080	C1999216
27655678	31	48	immunosuppression	T047	C4048329
27655678	52	84	myeloid-derived suppressor cells	T025	C4277543
27655678	85	117	Myeloid-derived-suppressor cells	T025	C4277543
27655678	119	124	MDSCs	T025	C4277543
27655678	147	165	immune suppression	T047	C1840264
27655678	173	186	ovarian tumor	T191	C0029925
27655678	187	203	microenvironment	T070	C2936626
27655678	205	215	Modulation	T082	C0443264
27655678	219	223	MDSC	T025	C4277543
27655678	224	232	function	T169	C0542341
27655678	244	261	immunosuppression	T047	C4048329
27655678	278	289	immunologic	T169	C0205470
27655678	303	309	tumors	T191	C0027651
27655678	315	347	bis-benzylidine piperidone RA190	T121	C1254351
27655678	361	379	ubiquitin receptor	T116,T129,T192	C0769158
27655678	380	391	RPN13/ADRM1	T116,T123	C1439083
27655678	399	422	19S regulatory particle	T026	C1518774
27655678	430	440	proteasome	T116,T126	C0208355
27655678	460	474	ovarian cancer	T191	C0029925
27655678	475	480	cells	T025	C0007634
27655678	495	513	proteotoxic stress	T067	C1254366
27655678	545	550	RA190	T121	C1254351
27655678	551	560	treatment	T061	C0087111
27655678	568	585	immunosuppression	T047	C4048329
27655678	597	602	MDSCs	T025	C4277543
27655678	610	632	tumor microenvironment	T070	C2936626
27655678	654	671	immunosuppression	T047	C4048329
27655678	683	688	MDSCs	T025	C4277543
27655678	703	708	RA190	T121	C1254351
27655678	721	731	expression	T045	C0597360
27655678	735	740	Stat3	T116,T123	C0253050
27655678	749	755	levels	T080	C0441889
27655678	763	780	immunosuppressive	T047	C4048329
27655678	781	788	enzymes	T116,T126	C0014442
27655678	793	802	cytokines	T116,T129	C0079189
27655678	803	811	arginase	T116,T126	C0003762
27655678	813	817	iNOS	T116,T126	C1565683
27655678	823	828	IL-10	T116,T129	C0085295
27655678	832	837	MDSCs	T025	C4277543
27655678	854	864	expression	T045	C0597360
27655678	872	889	immunostimulatory	T061	C0087111
27655678	890	898	cytokine	T116,T129	C0079189
27655678	899	904	IL-12	T116,T121,T129	C0123759
27655678	936	941	RA190	T121	C1254351
27655678	951	956	MDSCs	T025	C4277543
27655678	980	988	suppress	T169	C1260953
27655678	989	1000	CD8+ T cell	T025	C0242629
27655678	1001	1009	function	T169	C0542341
27655678	1033	1038	RA190	T121	C1254351
27655678	1039	1048	treatment	T061	C0087111
27655678	1052	1056	mice	T015	C0026809
27655678	1065	1074	syngeneic	T080	C2348628
27655678	1075	1088	ovarian tumor	T191	C0029925
27655678	1104	1115	CD8+ T cell	T025	C0242629
27655678	1116	1125	antitumor	T080	C2986475
27655678	1126	1142	immune responses	T042	C0301872
27655678	1156	1161	tumor	T191	C0027651
27655678	1162	1169	control	T080	C0243148
27655678	1174	1182	survival	T169	C0220921
27655678	1190	1194	data	T078	C1511726
27655678	1220	1225	RA190	T121	C1254351
27655678	1230	1244	ovarian cancer	T191	C0029925
27655678	1245	1254	treatment	T061	C0087111
27655678	1270	1277	killing	T043	C0599733
27655678	1281	1292	tumor cells	T025	C0597032
27655678	1297	1318	proteasome inhibition	T044	C1514526
27655678	1333	1337	MDSC	T025	C4277543
27655678	1348	1359	suppression	T169	C1260953
27655678	1363	1373	CD8 T cell	T025	C0242629
27655678	1385	1394	antitumor	T080	C2986475
27655678	1395	1403	immunity	T039	C0020964
27655678	1420	1429	apoptotic	T080	C1516044
27655678	1430	1441	tumor cells	T025	C0597032